Coherus BioSciences
CHRS
#8809
Rank
HK$1.21 B
Marketcap
HK$10.05
Share price
7.62%
Change (1 day)
-24.03%
Change (1 year)

Revenue for Coherus BioSciences (CHRS)

Revenue in 2025 (TTM): HK$0.65 Billion

According to Coherus BioSciences 's latest financial reports the company's current revenue (TTM ) is HK$0.65 Billion. In 2024 the company made a revenue of HK$0.56 Billion a decrease over the revenue in the year 2023 that were of HK$2.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Coherus BioSciences from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$0.65 B15.01%
2024 HK$0.56 B-71.87%
2023 HK$2.00 B21.84%
2022 HK$1.64 B-35.24%
2021 HK$2.54 B-30.97%
2020 HK$3.68 B33.02%
2019 HK$2.77 B
2018 N/A-100%
2017 HK$12.15 M-99.18%
2016 HK$1.47 B533.14%
2015 HK$0.23 B-3.5%
2014 HK$0.24 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Acorda Therapeutics
ACOR
HK$0.89 B 38.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
HK$2.9 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$279.83 B 42,943.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$5.50 B 747.08%๐Ÿ‡บ๐Ÿ‡ธ USA